Tech & Pharma

Floating Solar Farms For India and Japan Floating Solar Farms For India and Japan
  • September 12th, 2014
  • Companies in Japan and India have started utilizing floating power farms to circumvent the lack of space on land.

» Read More...

Tech & Pharma

Floating Solar Farms For India and Japan

Floating Solar Farms For India and Japan

Companies in Japan and India have started utilizing floating power farms to circumvent the lack of space on land.

ASLAN Commences Taiwan Trials For Gastric Cancer Drug

ASLAN Commences Taiwan Trials For Gastric Cancer Drug

ASLAN has begun treating its first gastric cancer patients in Taiwan, where 4,000 people are affected by the disease annually.

ToolGen & KAIST To Collaborate On Biofuel Gene Editing

ToolGen & KAIST To Collaborate On Biofuel Gene Editing

KAIST partners gene editing company ToolGen to develop methods of increasing biofuel yield from microalgae.

Biocon Runs Free Oral Cancer Screens In India

Biocon Runs Free Oral Cancer Screens In India

Biocon organized a week of free oral cancer screening activities across 23 Indian cities from September 1-7, 2014.

Luye Acquires Jialin for US$600 Million

Luye Acquires Jialin for US$600 Million

Luye Pharma strengthens its position in China’s cardiovascular drug market with the US$600 million acquisition of Beijing Jialin Pharmaceutical.

Making Driverless Cars A Reality

Making Driverless Cars A Reality

Singapore’s A*STAR and LTA have set up a partnership to propel the development of automated vehicle systems within the country.

Turning Waste Heat Into Air Conditioning

Turning Waste Heat Into Air Conditioning

The Combined Heat and Power plant jointly developed by A*STAR and Hitachi achieves high efficiency with low operation costs.

Eisai & Zeria To Develop Gastic Acid Drug

Eisai & Zeria To Develop Gastic Acid Drug

Eisai grants Zeria the right to manufacture E3710, a proton pump inhibitor than can be used to treat gastric acid-related diseases.

South Korean FDA Approval For Green Cross’ Neulapeg®

South Korean FDA Approval For Green Cross’ Neulapeg®

Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.

Amerigen’s Mecobalamin Receives CFDA Approval

Amerigen’s Mecobalamin Receives CFDA Approval

The CFDA approval of Mecobalamin marks Amerigen’s entry into the Chinese generics market.